Senseonics Holdings, Inc. Reports Second Quarter 2023 Financial Results

10.08.2023 - Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial ...

Related Keywords

United States ,American ,Tim Goodnow ,Nurse Practitioner Group ,Senseonics Holdings Inc ,American Diabetes Association ,Scientific Sessions ,Eversense System ,Ascensia Diabetes Care ,Chief Executive Officer ,Webcast Information ,Eastern Time ,Teleconference Information ,Private Securities Litigation Reform Act ,Senseonic Annual Report ,Quarterly Report ,Stockholder Equity ,Condensed Consolidated Statements ,Comprehensive Income ,